Published July, 2013
Perspectives on the ethical concerns and justifications of the 2006 Centers for Disease Control and Prevention HIV testing recommendations, Michael J. Waxman, Roland C. Merchant, M. Teresa Celada, and Melissa A. Clark, BMC Medical Ethics (2011)
This article summarizes perceived ethical merits and demerits of the Centers for Disease Control and Prevention (CDC)'s 2006 guidelines for HIV testing methods in U.S. clinical settings. While stating a continued commitment to "informed consent," the revised guidelines recommended an "opt-out" approach that eliminates explanations of the test and HIV, elimination of patient signatures to document consent, and optional as opposed to mandatory HIV prevention counseling. The recommendations were designed to encourage providers to increase HIV testing by eliminating the need to counsel and elicit consent that some doctors found burdensome. The article claimed that commentators "singled out harms or benefits" without weighing their relative costs and gains against each other, and attempted to objectively present these costs and benefits. Based on interviews with academics, members of advocacy groups, clinicians, policymakers, and researchers, the authors set forth common concerns and possible benefits regarding the changes, including possible loss of patient autonomy as well as increased rates of testing and early detection of HIV.
Copyright Information: CHLP encourages the broad use and sharing of resources. Please credit CHLP when using these materials or their content. and do not alter, adapt or present as your work without prior permission from CHLP.
Legal Disclaimer: CHLP makes an effort to ensure legal information is correct and current, but the law is regularly changing, and the accuracy of the information provided cannot be guaranteed. The legal information in a given resource may not be applicable to all situations and is not—and should not be relied upon—as a substitute for legal advice.